USP10 and steatosis: Interestingly, the USP10 and C/EBPβ protein levels were increased in the livers of spautin-1–treated HFD mice (Fig. 7c–d), which is opposite to the pattern observed in the adipose tissue but consistent with reports linking hepatic USP10 upregulation with steatosis improvement [22].